Appendix 4D and FY26 Interim Report
| Stock | Beamtree Holdings Ltd (BMT.ASX) |
|---|---|
| Release Time | 19 Feb 2026, 8:24 a.m. |
| Price Sensitive | Yes |
Beamtree Reports FY26 Interim Results
- Recurring revenue grew 10% year-over-year
- Positive operating profit of $61k, up from $5k in prior period
- Continued progress on AI-enabled products, including Autonomous Coding and Evolve Analytics
Beamtree Holdings Ltd, a leading provider of AI-based decision support and data insights solutions for the healthcare industry, has reported its financial results for the first half of FY26. The company saw a 10% increase in recurring revenue, underpinned by strong performance across its Coding, Knowledge Networks, and Diagnostics segments. Operating profit reached $61k, up from $5k in the prior corresponding period, as the company maintained discipline on its cost base while investing in international expansion and the development of new AI-enabled products. Key milestones included the launch of the Evolve analytics platform in the UK, successful pilots of the Autonomous Coding Solution in Australia, the UK, and Canada, and the co-development of an Autonomous Data Entry solution with a major Australian pathology provider. Beamtree also took steps to simplify its operating model, including a reset of its ARR reporting framework, the appointment of a new CFO and GM of Sales (ANZ), and tighter forecasting and cost controls. Looking ahead, the company is well-positioned for accelerated growth in the second half, with customer-led AI solutions progressing to commercial deployment and a strengthened go-to-market capability. The Board has also commenced a strategic review to further unlock shareholder value.
Beamtree expects to see accelerated ARR growth in H2 FY26 and beyond, driven by the commercial deployment of its AI-enabled products and continued strong demand across its core markets.
Beamtree is well-positioned for the next phase of growth, with a simplified operating model, strengthened go-to-market capabilities, and a pipeline of customer-led AI solutions progressing to commercial deployment. The company is focused on driving accelerated ARR growth while also exploring strategic options to unlock shareholder value.